Rimegepant in Real-World Migraine Prevention
A real-world study shows rimegepant effectively prevents migraines in treatment-resistant patients, including some after CGRP antibody failure, supporting earlier use for improved long-term outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.